Ketamine for Treatment-Resistant Depression / Najlacnejšie knihy
Ketamine for Treatment-Resistant Depression

Kód: 13496445

Ketamine for Treatment-Resistant Depression

Autor Sanjay J. Mathew, Carlos A. Zarate Jr.

Representing the first scholarly compendium of information in the field, this book provides a synopsis of the scientific literature that is equally useful to new and experienced investigators. Recent research in the use of ketamin ... celý popis

131.04


Skladom u dodávateľa
Odosielame za 11 - 13 dní
Pridať medzi želanie

Mohlo by sa vám tiež páčiť

Darčekový poukaz: Radosť zaručená
  1. Darujte poukaz v ľubovoľnej hodnote, a my sa postaráme o zvyšok.
  2. Poukaz sa vzťahuje na všetky produkty v našej ponuke.
  3. Elektronický poukaz si vytlačíte z e-mailu a môžete ho ihneď darovať.
  4. Platnosť poukazu je 12 mesiacov od dátumu vystavenia.

Objednať darčekový poukazViac informácií

Viac informácií o knihe Ketamine for Treatment-Resistant Depression

Nákupom získate 324 bodov

Anotácia knihy

Representing the first scholarly compendium of information in the field, this book provides a synopsis of the scientific literature that is equally useful to new and experienced investigators. Recent research in the use of ketamine for difficult-to-treat depressive disorders and related conditions is presented, as is an examination of how insights from these studies are forging new conceptual models of the neurobiology of stress-related affective and addictive disorders, and the nature of treatment-resistance. In addition, the book discusses how ketamine's rapid antidepressant effects provide a scientific platform to facilitate innovation in clinical trial design, including patient selection, choice of control group, outcome measures, and dose-optimization.§§There is surging worldwide interest in the use of ketamine therapy, and this work collects the insights of many of the world's leading researchers in this nascent clinical and scientific field. This book has appeal to researchers (both clinical and basic), clinicians, health care administrators, and patients. Researchers will benefit from an updated discussion of neurobiological mechanisms and hypothesized actions of ketamine in neural circuits. Clinicians benefit from a clear summary of safety and efficacy data, which will permit informed choices regarding the risk-to-benefit ratio for administration of ketamine to patients.§§

Parametre knihy

Zaradenie knihy Knihy po anglicky Medicine Other branches of medicine Pharmacology

131.04

Obľúbené z iného súdka



Osobný odber Bratislava a 2642 dalších

Copyright ©2008-24 najlacnejsie-knihy.sk Všetky práva vyhradenéSúkromieCookies


Môj účet: Prihlásiť sa
Všetky knihy sveta na jednom mieste. Navyše za skvelé ceny.

Nákupný košík ( prázdny )

Vyzdvihnutie v Zásielkovni
zadarmo nad 59,99 €.

Nachádzate sa: